LOCUSTAMYOTROPIN IV(143907-81-7)
- Name: LOCUSTAMYOTROPIN IV
- Synonyms:LocustamyotropinIV (9CI); Lom-MT-4; Lom-PK 6; Myotropin 4 (Locusta migratoria)
- Molecular Formula:C68H110 N24 O16 S
- Molecular Weight:1551.82
- CAS Registry Number:143907-81-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.143907-81-7 LOCUSTAMYOTROPIN IV
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.143907-81-7 LOCUSTAMYOTROPIN IV
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:LOCUSTAMYOTROPIN IV
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.143907-81-7 Locustamyotropin IV
Assay:99% Appearance:White to light yellow to light orange fluffy powder Package:according to your requirement Storage:White to light yellow to light orange fluffy powder Transportation:by air /by train/by sea Application:lab
Min. Order:1Kilogram
Supplier:Jiangsu Xinsu New Materials Co., Ltd. [
China (Mainland)]
Other Product
- 7238-03-1/copper(2+) 8-({2-[(octahydro-2H-quinolin-1-id-8-yloxy)methyl]benzyl}oxy)-2H-quinolin-1-ide - nitric acid (1:1:2)
- 65847-85-0/Morniflumate
- 91045-28-2/6-bromo-3-(2-{1-[(1-methylpiperidin-4-yl)methyl]-1H-benzimidazol-2-yl}phenyl)-2-phenylquinazolin-4(3H)-one
- 163314-07-6/4-Piperidinol,1-[(3-iodophenyl)methyl]-3-spiro[1H-indene-1,4'-piperidin]-1'-yl-, trans- (9CI)
- 5453-57-6/ethyl 3-oxo-3-phenyl-2-[(E)-phenyldiazenyl]propanoate
- 20405-19-0/bis(2-hydroxyethyl)ammonium 4-chloro-o-tolyloxyacetate
- 1110-02-7/Cucurbitacin L
- 50309-48-3/1-[[5-ethyl-2,4,6-trioxo-5-phenyl-3-[(N-phenylcarbamimidoyl)sulfanylmethyl]-1,3-diazinan-1-yl]methylsulfanyl]-N-phenyl-methanimidamide dihydrobromide
- 123562-49-2/(1R)-8β-[6-O-[(E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]-β-D-glucopyranosyloxy]-4,4aβ,8,8aβ-tetrahydro-1β-methyl-3-oxo-1H,3H-pyrano[3,4-c]pyran-5-carboxylic acid
- 90530-06-6/2-Propanol, 1,1-((3-((2-hydroxypropyl)amino)propyl)imino)bis-, N-(3-(C12-18-alkyloxy)propyl) derivs.
- 69742-90-1/2-Propanone,1-[5-[(2,4-dinitrophenyl)thio]-2,4-dinitro-2,4-cyclohexadien-1-yl]-, ion(1-),potassium (9CI)
- 5131-29-3/methyl 2-({[(5-{[(3-chlorophenyl)amino]methyl}-4-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetyl}amino)benzoate
- 74037-69-7/4-[1-(4-chlorophenyl)butyl]morpholine hydrochloride
- 67953-70-2/2-Propenoic acid,2-methyl-,esters,ethyl ester,polymer with ethyl 2-propenoate and methyl 2-propenoate
- 68958-58-7/PEG-15 GLYCERYL ISOSTEARATE
- 68908-67-8/Ethanol, 2,2-iminobis-, N-(3-(C12-15-alkyloxy)propyl) derivs. alpha-methyl derivs, N-oxides
- 5455-66-3/4-Methyl-2-pentyl-1,3-dioxane
- 143907-81-7/LOCUSTAMYOTROPIN IV
- 52888-73-0/7-Hydroxytetralin-6-carboxylic acid methyl ester
- 1502-22-3/2-(1-CYCLOHEXENYL)CYCLOHEXANONE
- 552-92-1/toloconium metilsulfate
- 4751-94-4/4-({(E)-amino[(diaminomethylidene)amino]methylidene}amino)benzenesulfonamide
- 545-22-2/Dammarane
- 84012-53-3/2-[[cyclohexyl(2-hydroxyethyl)amino]methyl]-1,2-benzisothiazol-3(2H)-one
- 112345-95-6/Piperidine,1-[(3,4-dichlorophenyl)acetyl]-2-(1- pyrrolidinylmethyl)-,monohydrochloride,(R)-
- 103596-05-0/methyl 3-hydroxy-9-oxo-9,10-seco-23,24-dinor-1,3,5(10)-cholatrienoate
- 81498-82-0/1-Cyclobutyl-3-methyl-3-nitrosourea
- 119637-73-9/glucagon-like peptide I (7-36)amide
- 68153-64-0/PEG-20 TALLOWATE
- 99541-52-3/3-[(4-benzylpiperidin-1-yl)methyl]-6-[(4-methoxyphenyl)carbonyl]-1,3-benzoxazol-2(3H)-one